Idiopathic Pulmonary Fibrosis: all 565 studies

Page 6 of 6. Open to participants first (117), then studies with results posted, then the rest; newest registration first within each.

• Conducting Airways in Lung Fibrosis (VACFI)CompletedNCT01777373
• Long Term Effects of an Inpatient Pulmonary Rehabilitation Program in Patients With Pulmonary FibrosisCompletedNCT01772667Not applicable
• Does CBT Improve the Perception/Impact of Cough and Breathlessness in IPF PatientsStatus unknownNCT01738711Not applicable
• A Proof of Mechanism Study With GSK2126458 in Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT01725139Phase 1
• Biomarker Discovery for Novel Drug Development in Idiopathic Pulmonary FibrosisCompletedNCT01718990
• The Role of Gastric Content Microaspirations in the Pathogenesis of Idiopathic Pulmonary FibrosisStatus unknownNCT01714934
• Investigating Significant Health Trends in Idiopathic Pulmonary FibrosisCompletedNCT01695408
• CPAP Therapy in Patients With Idiopathic Pulmonary Fibrosis and Sleep ApneaCompletedNCT01637831Not applicable
• To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT01529853Phase 1/2
• A MultiCenter Study of Combined PEX, Rituximab, and Steroids in Acute Idiopathic Pulmonary Fibrosis ExacerbationsWithdrawnNCT01524068Phase 2
• Safety and Efficacy Study of Pirfenidone to Treat Idiopathic Pulmonary Fibrosis(IPF)Status unknownNCT01504334Phase 2
• Exercise Training at Ambulatory Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis PatientsStatus unknownNCT01499745Not applicable
• Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT01462006Not applicable
• IPF Drug Deposition StudyCompletedNCT01457261Phase 1
• Acute Effect of Sildenafil on Exercise Tolerance and Functional Capacity in COPD, IPF and Post Pneumonectomy PatientsStatus unknownNCT01382368Phase 4
• A Study to Evaluate the Safety and Efficacy of GS-6624 (Formerly AB0024) in Patients With Idiopathic Pulmonary FibrosisCompletedNCT01362231Phase 1
• Safety and Tolerability Study of Macitentan in Patients With Idiopathic Pulmonary FibrosisWithdrawnNCT01346930Phase 2
• 68Ga-DOTA-NOC PET/CT in Patients With Idiopathic Pulmonary FibrosisTerminatedNCT01321996Phase 4
• Safety and Efficacy of QAX576 in Patients With Idiopathic Pulmonary Fibrosis (IPF)TerminatedNCT01266135Phase 2
• Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl.CompletedNCT01265888Phase 2
• Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary FibrosisCompletedNCT01262001Phase 2
• A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF)TerminatedNCT01203943Phase 2
• Trial Of IW001 in Patients With Idiopathic Pulmonary FibrosisCompletedNCT01199887Phase 1
• Case-Control Study of Fibrotic Interstitial Lung Disease (ILD) and Cardiac Disease / Interventions.Status unknownNCT01154998
• Microaspiration in Pulmonary FibrosisCompletedNCT01150591
• Pomalidomide for Cough in Patients With Idiopathic Pulmonary FibrosisWithdrawnNCT01135199Phase 2
• Prospective Study of Fibrosis In the Lung Endpoints (PROFILE - Central England)CompletedNCT01134822
• Prospective Observation of Fibrosis in the Lung Clinical Endpoints StudyCompletedNCT01110694
• Beneficial Effects of Pulmonary Rehabilitation for Idiopathic Pulmonary FibrosisCompletedNCT01107028
• Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT01071707
• Idiopathic Pulmonary Fibrosis Registry for Future StudiesCompletedNCT00815711
• A Study to Evaluate the Safety and Effectiveness of CNTO 888 Administered Intravenously (IV) in Participants With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT00786201Phase 2
• Pulmonary Rehabilitation for Idiopathic Pulmonary FibrosisCompletedNCT00692796Not applicable
• Interferon-alpha Treatment of Chronic Cough in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary FibrosisTerminatedNCT00690885Phase 2
• Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT00639496Phase 3
• Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment StudyStatus unknownNCT00637065Phase 4
• Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With BosentanWithdrawnNCT00625469Phase 4
• Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With SildenafilWithdrawnNCT00625079Phase 4
• A Pilot Study of Aerosol Interferon-gamma for Treatment of Idiopathic Pulmonary FibrosisCompletedNCT00563212Phase 1
• Pennsylvania Idiopathic Pulmonary Fibrosis Research RegistryCompletedNCT00540475
• SD, IL-13 Production Rate in IPFCompletedNCT00532233Phase 2
• Azathioprine and Prednisone in the Treatment of Idiopathic Pulmonary FibrosisStatus unknownNCT00518310Not applicable
• The Occurence of Inflammation and Oxidative Stress in Lung DiseasesCompletedNCT00512967
• Treatment of Idiopathic Pulmonary Fibrosis with Long Acting OctreotideCompletedNCT00463983Phase 1/2
• Race, Ethnicity, and Diffuse Parenchymal Lung DiseaseCompletedNCT00453713
• Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary HypertensionCompletedNCT00352482Phase 2
• Zileuton for the Treatment of Idiopathic Pulmonary FibrosisCompletedNCT00262405Phase 2
• Herpesvirus in Idiopathic Pulmonary FibrosisCompletedNCT00228670
• Evaluation of Patients With Idiopathic Pulmonary Fibrosis (IPF) Through an IPF RegistryWithdrawnNCT00212511
• Minocycline Therapy for Lung Scarring in Patients With Idiopathic Pulmonary Fibrosis - a Pilot StudyStatus unknownNCT00203697Phase 3
• Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary FibrosisCompletedNCT00189176Phase 1/2
• Pulmonary Rehabilitation in Interstitial Lung DiseaseStatus unknownNCT00168285Not applicable
• Treatment of Idiopathic Pulmonary Fibrosis With ThalidomideCompletedNCT00162760Phase 2
• Gleevec Idiopathic Pulmonary Fibrosis (IPF) StudyCompletedNCT00131274Phase 2/3
• Study of GC1008 in Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT00125385Phase 1
• Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary FibrosisCompletedNCT00109681Phase 2
• An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPFTerminatedNCT00076635Phase 3
• The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF)TerminatedNCT00075998Phase 3
• Safety and Tolerability Study of FG-3019 in Participants With Idiopathic Pulmonary FibrosisCompletedNCT00074698Phase 1
• Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary FibrosisCompletedNCT00071461Phase 2/3
• Study Evaluating the Safety and Efficacy of Etanercept in Patients With Idiopathic Pulmonary FibrosisCompletedNCT00063869Phase 2
• An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT00052052Phase 2
• A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving PrednisoneTerminatedNCT00052039Phase 3
• A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT00047658Phase 2
• A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT00047645Phase 3

← Idiopathic Pulmonary Fibrosis overview